0001826834-20-000001.txt : 20201002 0001826834-20-000001.hdr.sgml : 20201002 20201002154511 ACCESSION NUMBER: 0001826834-20-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20201002 DATE AS OF CHANGE: 20201002 EFFECTIVENESS DATE: 20201002 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Biopharmaceutical Research Co CENTRAL INDEX KEY: 0001826834 IRS NUMBER: 820650107 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-377015 FILM NUMBER: 201219794 BUSINESS ADDRESS: STREET 1: 11045 COMMERCIAL PARKWAY CITY: CASTROVILLE STATE: CA ZIP: 95012 BUSINESS PHONE: 831-632-0913 MAIL ADDRESS: STREET 1: 11045 COMMERCIAL PARKWAY CITY: CASTROVILLE STATE: CA ZIP: 95012 D 1 primary_doc.xml X0708 D LIVE 0001826834 Biopharmaceutical Research Co 11045 COMMERCIAL PARKWAY CASTROVILLE CA CALIFORNIA 95012 831-632-0913 DELAWARE Biopharmaceutical Research Company, LLC None Corporation true 2017 George Hodgin 11045 Commercial Parkway Castroville CA CALIFORNIA 95012 Executive Officer Director Charles Schumacher 11045 Commercial Parkway Castroville CA CALIFORNIA 95012 Director Other Technology Decline to Disclose 06b false 2020-09-18 false true true false 0 North Point Advisors, Inc. 133300 North Point Advisors, Inc. 133300 580 California Street, Suite 2000 San Francisco CA CALIFORNIA 94104 AZ ARIZONA CA CALIFORNIA CO COLORADO CT CONNECTICUT DC DISTRICT OF COLUMBIA HI HAWAII IL ILLINOIS MA MASSACHUSETTS MI MICHIGAN NJ NEW JERSEY NY NEW YORK NC NORTH CAROLINA PA PENNSYLVANIA PR PUERTO RICO TX TEXAS UT UTAH WA WASHINGTON false 3000000 2045000 955000 false 17 122700 true 0 North Point Advisors, Inc. will also receive a to be determined number of warrants to purchase shares of the issuer. 0 false Biopharmaceutical Research Co /s/ George Hodgin George Hodgin Chief Executive Officer 2020-10-02